Helping cancer survivors manage symptoms and reduce distress during treatment

Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors

NIH-funded research University of Arizona · NIH-11078665

This study is testing a helpful phone system that lets cancer survivors share their symptoms each week, so their healthcare team can quickly support them, especially if they're feeling really stressed, making it easier for them to manage their health during treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona NIH-funded
Lab location1 site (Tucson, United States)
Project IDNIH-11078665 on NIH RePORTER

What this research studies

This research focuses on improving the management of symptoms experienced by cancer survivors undergoing treatment with immune checkpoint inhibitors. It utilizes an Automated Telephone Symptom Management system that allows patients to report their symptoms weekly, which helps healthcare providers monitor and address any issues promptly. The study involves a randomized trial design, where participants may receive additional support if their psychological distress remains high. The goal is to empower survivors with effective self-management strategies and timely communication with their healthcare team.

Who could benefit from this research

Good fit: Ideal candidates are cancer survivors who are within 12 weeks of starting immune checkpoint inhibitor therapy and are experiencing elevated psychological distress.

Not a fit: Patients who are not currently undergoing treatment with immune checkpoint inhibitors or those without significant psychological distress may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better symptom management and reduced psychological distress for cancer survivors on immune checkpoint inhibitors.

How similar studies have performed: Previous research has shown that similar approaches to symptom management and patient self-reporting can lead to improved outcomes, indicating potential success for this study.

Where this research is happening

Tucson, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions anti-cancer therapyCancer Survivorcancer therapyCancer Treatmentcancer type
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.